Dimensional Fund Advisors
AMLX icon

Dimensional Fund Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History

Dimensional Fund Advisors’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.16M Sell
108,752
-793,711
-88% -$21M ﹤0.01% 2613
2026
Q2 		$16.2M Sell
902,463
-729
-0.1% -$11.3K ﹤0.01% 2127
2026
Q1 		$12.5M Buy
903,192
+131,944
+17% +$1.86M ﹤0.01% 2171
2025
Q4 		$9.32M Buy
771,248
+261,468
+51% +$3.55M ﹤0.01% 2305
2025
Q3 		$6.94M Buy
509,780
+136,041
+36% +$1.28M ﹤0.01% 2433
2025
Q2 		$2.4M Buy
373,739
+250,163
+202% +$1.22M ﹤0.01% 2719
2025
Q1 		$438K Buy
123,576
+69,462
+128% +$247K ﹤0.01% 3021
2024
Q4 		$205K Buy
+54,114
New +$255K ﹤0.01% 3163

Other funds holding AMLX

Moody Aldrich Partners
Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
iA Global Asset Management
iA Global Asset Management Quebec, Quebec, Canada $8.54B AUM 39.73% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Parsons Capital Management
Parsons Capital Management Providence, Rhode Island $2.29B AUM 21.99% 1-Year Est. Return

Dimensional Fund Advisors's AMLX Position: Q3 2026 in Review

Dimensional Fund Advisors reduced its Amylyx Pharmaceuticals (AMLX) stake by 88% in Q3 2026, selling an estimated $21M and leaving 108,752 shares worth $3.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2613.

Dimensional Fund Advisors first reported a position in AMLX in Q4 2024 and has held it in 8 quarters since. The position peaked at $16.2M in Q2 2026. 50 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.

  • Dimensional Fund Advisors held 108,752 shares of Amylyx Pharmaceuticals worth $3.16M as of Q3 2026.
  • Dimensional Fund Advisors sold 793,711 Amylyx Pharmaceuticals shares in Q3 2026, an estimated $21M.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2613 holding.
  • Dimensional Fund Advisors first reported a position in Amylyx Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • Dimensional Fund Advisors's Amylyx Pharmaceuticals position peaked at $16.2M in Q2 2026.
  • 50 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.